Paper34867280
Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1.
Liu J and 4 others. Front Aging Neurosci, 2021. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1. Papers, record 34867280. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34867280
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References380
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23042586 | Fatigue and daytime sleepiness scale in myotonic dystrophy type 1. | Muscle Nerve | 2013 | https://conductscience.org/library/papers/23042586 | PubMed |
| 2 | 22078098 | Myoblasts generated by lentiviral mediated MyoD transduction of myotonic dystrophy type 1 (DM1) fibroblasts can be used for assays of therapeutic molecules. | BMC Res Notes | 2011 | https://conductscience.org/library/papers/22078098 | PubMed |
| 3 | 27313901 | Brain Connectomics' Modification to Clarify Motor and Nonmotor Features of Myotonic Dystrophy Type 1. | Neural Plast | 2016 | https://conductscience.org/library/papers/27313901 | PubMed |
| 4 | 31216018 | MSH3 modifies somatic instability and disease severity in Huntington's and myotonic dystrophy type 1. | Brain | 2019 | https://conductscience.org/library/papers/31216018 | PubMed |
| 5 | 31479430 | Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice. | J Clin Invest | 2019 | https://conductscience.org/library/papers/31479430 | PubMed |
| 6 | 23629807 | Somatic instability of CTG repeats in the cerebellum of myotonic dystrophy type 1. | Muscle Nerve | 2013 | https://conductscience.org/library/papers/23629807 | PubMed |
| 7 | 25003008 | GSK3β is a new therapeutic target for myotonic dystrophy type 1. | Rare Dis | 2013 | https://conductscience.org/library/papers/25003008 | PubMed |
| 8 | 33669654 | Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/33669654 | PubMed |
| 9 | 16908973 | The TAT protein transduction domain enhances the neuroprotective effect of glial-cell-line-derived neurotrophic factor after optic nerve transection. | Neurodegener Dis | 2004 | https://conductscience.org/library/papers/16908973 | PubMed |
| 10 | 26484877 | Reconstructing the Rasch-Built Myotonic Dystrophy Type 1 Activity and Participation Scale. | PLoS One | 2015 | https://conductscience.org/library/papers/26484877 | PubMed |
| 11 | 27660412 | Intranasal administration of elastin-like polypeptide for therapeutic delivery to the central nervous system. | Drug Des Devel Ther | 2016 | https://conductscience.org/library/papers/27660412 | PubMed |
| 12 | 32683410 | MBNL1 reverses the proliferation defect of skeletal muscle satellite cells in myotonic dystrophy type 1 by inhibiting autophagy via the mTOR pathway. | Cell Death Dis | 2020 | https://conductscience.org/library/papers/32683410 | PubMed |
| 13 | 31010208 | Dysregulation of Circular RNAs in Myotonic Dystrophy Type 1. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31010208 | PubMed |
| 14 | 18930147 | Intergenerational and striatal CAG repeat instability in Huntington's disease knock-in mice involve different DNA repair genes. | Neurobiol Dis | 2009 | https://conductscience.org/library/papers/18930147 | PubMed |
| 15 | 31754023 | Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/31754023 | PubMed |
| 16 | 22861906 | Psychiatric and cognitive phenotype of childhood myotonic dystrophy type 1. | Dev Med Child Neurol | 2012 | https://conductscience.org/library/papers/22861906 | PubMed |
| 17 | 24092878 | Transcriptional changes and developmental abnormalities in a zebrafish model of myotonic dystrophy type 1. | Dis Model Mech | 2014 | https://conductscience.org/library/papers/24092878 | PubMed |
| 18 | 20360842 | Muscleblind1, but not Dmpk or Six5, contributes to a complex phenotype of muscular and motivational deficits in mouse models of myotonic dystrophy. | PLoS One | 2010 | https://conductscience.org/library/papers/20360842 | PubMed |
| 19 | 25115999 | Cognitive impairment in myotonic dystrophy type 1 is associated with white matter damage. | PLoS One | 2014 | https://conductscience.org/library/papers/25115999 | PubMed |
| 20 | 21792905 | Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. | J Cell Physiol | 2011 | https://conductscience.org/library/papers/21792905 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42908507 | Structural changes in the retinal layers of patients with Steinert disease. | Front Ophthalmol (Lausanne) | 2026 | https://conductscience.org/library/papers/42908507 | PubMed |
| 42486096 | Fatty-acid-based antimiR-23b delivery in the DMSXL model: A potential therapeutic strategy for brain dysfunction in myotonic dystrophy type 1. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42486096 | PubMed |
| 42104406 | CELF family of RNA-binding proteins: roles in disease biology and potential for therapeutic intervention. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42104406 | PubMed |
| 41303475 | Cardiac Involvement in Myotonic Dystrophy Type 1: Mechanisms, Clinical Perspectives, and Emerging Therapeutic Strategies. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41303475 | PubMed |
| 40917546 | Muscle-driven spinal cord histological and transcriptomic alterations in a myotonic dystrophy mouse model: insights into neuropathy. | Brain Commun | 2025 | https://conductscience.org/library/papers/40917546 | PubMed |
| 40508159 | Multisystem Symptoms in Myotonic Dystrophy Type 1: A Management and Therapeutic Perspective. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40508159 | PubMed |
| 39444647 | Fetal Brain MRI Findings in Myotonic Dystrophy and Considerations for Prenatal Genetic Testing. | Neurol Genet | 2024 | https://conductscience.org/library/papers/39444647 | PubMed |
| 38638300 | Cognitive impairment, neuroimaging abnormalities, and their correlations in myotonic dystrophy: a comprehensive review. | Front Cell Neurosci | 2024 | https://conductscience.org/library/papers/38638300 | PubMed |
| 38556838 | The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes. | Alzheimers Dement | 2024 | https://conductscience.org/library/papers/38556838 | PubMed |
| 37799732 | Analyzing alternative splicing in Alzheimer's disease postmortem brain: a cell-level perspective. | Front Mol Neurosci | 2023 | https://conductscience.org/library/papers/37799732 | PubMed |
| 36935893 | Excessive rest time during active phase is reliably detected in a mouse model of myotonic dystrophy type 1 using home cage monitoring. | Front Behav Neurosci | 2023 | https://conductscience.org/library/papers/36935893 | PubMed |
| 36911946 | Central Bradypnea and Ataxic Breathing in Myotonic Dystrophy Type 1 - A Clinical Case Report. | J Neuromuscul Dis | 2023 | https://conductscience.org/library/papers/36911946 | PubMed |
| 36142405 | Development of Therapeutic Approaches for Myotonic Dystrophies Type 1 and Type 2. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36142405 | PubMed |
Genes45
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34867280
GET https://conductscience.org/api/papers/v1/34867280/references?page=2